(Q35060342)

6 August 2017

1 reference

title

Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions (English)

1 reference

6 August 2017

1 reference

1

Kelly-Anne Phillips

1 reference

6 August 2017

Jürg Bernhard

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Journal of the National Cancer Institute

6 August 2017

published in

1 reference

6 August 2017

volume

95

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

190-197

1 reference

6 August 2017

cites work

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from rat cerebral cortical synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estrogen as a growth factor to central nervous cells. Estrogen treatment promotes development of acetylcholinesterase-positive basal forebrain neurons transplanted in the anterior eye chamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Synaptogenic action of sex steroids in developing and adult neuroendocrine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Variations in sex-related cognitive abilities across the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The sex difference on one test of spatial visualization: a nontrivial difference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Effects of estrogen on memory function in surgically menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estrogen replacement therapy and cognitive function in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Cognitive function in postmenopausal women treated with raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

The induction by testosterone of aromatase activity in the preoptic area and activation of copulatory behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Aromatase immunoreactivity in axon terminals of the vertebrate brain. An immunocytochemical study on quail, rat, monkey and human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Aromatase in the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

Mild cognitive impairment: potential pharmacological treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F95.3.190

21 January 2018

Identifiers

DOI

10.1093/JNCI/95.3.190

1 reference

6 August 2017

1 reference